Estimated Burden of Coccidioidomycosis

Abstract

In this cross-sectional study, the estimated national burden of symptomatic coccidioidomycosis in 2019 was 10 to 18 times higher than the number of cases reported through national surveillance. Better awareness, diagnostic testing practices, and reporting are needed to improve patient outcomes and enhance our understanding of coccidioidomycosis epidemiology.